Tradestie Institutional Equity Comparison Engine

CAPR vs MESO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CAPR Overall Edge

CAPR Captures Institutional Edge (4โ€“0 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Capricor Therapeutics Inc (CAPR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CAPR trades at 78.7x Forward P/E with 0.0% operating margin (-7.9% YoY revenue) versus MESO at N/M Forward P/E and -42.6% operating margin (+390.7% YoY). In options structure, CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro) against MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CAPR
CAPR 78.7x vs MESO N/M Fwd P/E
Growth & Margin Winner CAPR
Op Margin 0.0% vs -42.6% ยท YoY -7.9% vs +390.7%
Momentum & Technical Winner CAPR
1Y +44.3% vs -16.4% ยท 52W Pos 15% vs 6%
Options & Structure Winner CAPR
CONSOLIDATION (89th %ile IV) vs UNCLASSIFIED (37th %ile IV)
CAPR NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap $595.4M
1M Return +26.23%
1Y Return +44.29%
Forward P/E 78.7x
Unified AI Score
28.0 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 50.0
MESO NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap $1.7B
1M Return -6.1%
1Y Return -16.42%
Forward P/E N/M
Unified AI Score
34.6 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CAPR +44.29% MESO -16.42% Spread: +63.21 pp (CAPR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CAPR TTM Op. Margin: 0.0% MESO TTM Op. Margin: -42.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CAPR vs MESO. Trailing 12-month operating profitability (CAPR 0.0% vs MESO -42.6%) and valuation multiples (CAPR 78.7x vs MESO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CAPR (5) vs MESO (5)
Institutional Metric CAPR MESO Criterion Row Winner
Market Capitalization Scale $595.4M $1.7B Larger Scale MESO
Trailing P/E Ratio Valuation 78.7x N/M Lower Multiple CAPR
Forward P/E Ratio Valuation 78.7x N/M Lower Multiple CAPR
Revenue Growth (YoY) Growth -7.9% +390.7% Higher Growth MESO
Operating Margin (TTM) Profitability 0.0% -42.6% Higher Margin CAPR
Net Profit Margin Profitability 0.0% -47.8% Higher Margin CAPR
Return on Equity (ROE) Capital Efficiency -100.5% -9.9% Higher ROE MESO
52-Week Range Position Momentum 15% ($3โ€“$40) 6% ($12โ€“$22) Stronger Trend CAPR
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 152% Vol 1.18ฮฒ ยท 78% Vol Lower Realized Risk MESO
Unified Institutional Score Composite Signal 28.0 / 100 (SELL) 34.6 / 100 (SELL) Higher Composite MESO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CAPR vs MESO Buy Guide
CAPR CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 89th %ile
IV Regime Extreme (>80th %ile)
Live CAPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MESO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MESO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CAPR nor MESO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.